Plants of the Melaleuca Genus as Antimicrobial Agents: From Farm to Pharmacy

Phytotherapy Research

Volumn 31, Issue 10, 2017, Pages 1475-1494

  Sharifi Rad, Javad ^a   Salehi, Bahare ^b   Varoni, Elena Maria ^c   Sharopov, Farukh ^d   Yousaf, Zubaida ^e   Ayatollahi, Seyed Abdulmajid ^a   Kobarfard, Farzad ^a   Sharifi Rad, Mehdi ^f   Afdjei, Mohammad Hossain ^g   Sharifi Rad, Majid ^h   Iriti, Marcello ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c UNIVERSITY OF MILAN   (Italy)

^d Avicenna Tajik State Medical University   (Tajikistan)

^e LAHORE COLLEGE FOR WOMEN UNIVERSITY   (Pakistan)

^f ZABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h UNIVERSITY OF ZABOL   (Iran)

Author keywords

Australian traditional medicine; methyl eugenol; Myrtaceae; tea tree oil; terpinen 4 ol, 1,8 cineol

Indexed keywords

ANTIINFECTIVE AGENT; CINEOLE; ESSENTIAL OIL; MELALEUCA EXTRACT; METHYLEUGENOL; PLANT EXTRACT; TERPINEN 4 OL; UNCLASSIFIED DRUG; 4-CYMENE; ALPHA-PINENE; ALPHA-TERPINEOL; CYCLOHEXANOL DERIVATIVE; CYCLOHEXENE DERIVATIVE; GAMMA-TERPINENE; LIMONENE; SABINENE; TEA TREE OIL; TERPENE; TERPINENOL-4; TERPINOLENE;

ACNE; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; CHEMICAL COMPOSITION; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG MECHANISM; EYE DISEASE; GINGIVITIS; HAND WASHING; HERPES LABIALIS; HUMAN; MELALEUCA; MELALEUCA ACUMINATA; MELALEUCA ALTERNIFOLIA; MELALEUCA ARMILLARIS; MELALEUCA CAJUPUTI; MELALEUCA CITRINA; MELALEUCA ERICIFOLIA; MELALEUCA HYPERICIFOLIA; MELALEUCA LEUCADENDRA; MELALEUCA LEUCADENDRON; MELALEUCA LINARIIFOLIA; MELALEUCA POLANDII; MELALEUCA QUINQUENERVIA; MELALEUCA STYPHELOIODES; MELALEUCA THYMIFOLIA; MELALEUCA VIMINALIS; MOUTH DISEASE; NONHUMAN; ONYCHOMYCOSIS; PATIENT SAFETY; PHYTOCHEMISTRY; REVIEW; TINEA PEDIS; TRADITIONAL MEDICINE; VAGINITIS; WOUND HEALING; CHEMISTRY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTI-INFECTIVE AGENTS; CYCLOHEXANOLS; CYCLOHEXENES; MELALEUCA; MONOTERPENES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TEA TREE OIL; TERPENES;

EID: 85027148464     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5880     Document Type: Review

References (145)

1. Al-Abd NM, Mohamed Nor Z, Mansor M, Azhar F, Hasan MS, Kassim M. 2015. Antioxidant, antibacterial activity, and phytochemical characterization of Melaleuca cajuputi extract. BMC Complement Altern Med 15: 385.
2. Amenta R, Camarda L, Di Stefano V, Lentini F, Venza F. 2000. Traditional medicine as a source of new therapeutic agents against psoriasis. Fitoterapia 71: S13–S20.
3. Amri I, Mancini E, De Martino L, et al. 2012. Chemical composition and biological activities of the essential oils from three Melaleuca species grown in Tunisia. Int J Mol Sci 13: 16580–16591.
4. Arweiler N, Donos N, Netuschil L, Reich E, Sculean A. 2000. Clinical and antibacterial effect of tea tree oil – a pilot study. Clin Oral Investig 4(2): 70–73.
5. Banes-Marshall L, Cawley P, Phillips CA. 2001. In vitro activity of Melaleuca alternifolia (tea tree) oil against bacterial and Candida spp. isolates from clinical specimens. Br J Biomed Sci 58: 139–145.
6. Barbosa LCA, Silva CJ, Teixeira RR, Meira RMS, Pinheiro AL. 2013. Chemistry and biological activities of essential oils from Melaleuca L. species. Agric Conspec Sci 78: 11–23.
7. Barker SC, Altman PM. 2010. A randomised, assessor blind, parallel group comparative efficacy trial of three products for the treatment of head lice in children-melaleuca oil and lavender oil, pyrethrins and piperonyl butoxide, and a “suffocation” product. BMC Dermatol 10(1): 6.
8. Belaiche. 1985. Treatment of skin infections, with the essential oil of Melaleuca alternifolia. Phytother 15(15): 15–17.
9. Blackwell A. 1991. Tea tree oil and anaerobic (bacterial) vaginosis. The Lancet 337(8736): 300.
10. Blackwood B, Thompson G, McMullan R, et al. 2013. Tea tree oil (5%) body wash versus standard care (Johnson's Baby Softwash) to prevent colonization with methicillin-resistant Staphylococcus aureus in critically ill adults: a randomized controlled trial. J Antimicrob Chemother 68(5): 1193–1199.
11. Bronstein AC, Spyker DA, Cantilena Jr LR, Rumack BH, Dart RC, 2012. 2011 annual report of the American Association of Poison Control Centers' National Poison data system (NPDS): 29th annual report. Taylor & Francis.
12. Brophy JJ. 1999. Potentially Commercial Melaleucas. Harwood Academic Publishers: Amsterdam, Netherlands; 247–274.
13. Brophy JJ, Lassak EV. 1988. Melaleuca leucadendra L. leaf oil:Two phenylpropanoid chemotypes. Flav Frag J 3: 43–46.
14. Brophy JJ, Davies NW, Southwell IA, Stiff IA, Williams LR. 1989. Gas chromatographic quality control for oil of Melaleuca terpinen-4-ol type (Australian tea tree). J Agric Food Chem 37: 1330–1335.
15. Brophy JJ, Goldsack RJ, Craven LA, O'Sullivan W. 2006. An investigation of the leaf oils of the western Australian broombush complex (Melaleuca uncinata Sens. Lat.) (Myrtaceae). J Essent Oil Res 18: 591–599.
16. Brophy JJ, Craven LA, Lebouvier N, Cabalion P, Nour M. 2012. An examination of the leaf essential oils of the endemic Melaleuca (Myrtaceae) species of New Caledonia. J Essent Oil Res 24: 273–278.
17. Brophy JJ, Craven LA, Doran JC. 2013. Melaleucas: Their Botany, Essential Oils and Uses. Australian Centre for International Agricultural Research: Canberra.
18. Brun V, Schumacher T. 1994. Traditional herbal medicine in Northern Thailand, Front Cover. Viggo Brun, Trond Schumacher. White Lotus: Herbs; 375.
19. Buck DS. 1994. Comparison of two topical preparations for the treatment of onyehornycosis: Melaleuca altemifilia (tea tree) oil and clotrimazole. J Fam Pract 38(6).
20. Budhiraja SS, Cullum ME, Sioutis SS, Evangelista L, Habanova ST. 1999. Biological activity of Melaleuca alternifolia (tea tree) oil component, terpinen-4-ol, in human myelocytic cell line HL-60. J Manipulative Physiol Ther 22(7): 447–453.
21. Caelli M, Porteous J, Carson C, Heller R, Riley T. 2001. Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. Int J Aromather 11(2): 97–99.
22. Camp RD. 2004. The wizard of Oz, or the intriguing tale of the tea tree. J Invest Dermatol 123(4): xviii–xvxix.
23. Carson CF, Riley TV. 1994. Susceptibility of Propionibacterium acnes to the essential oil of Melaleuca alternifolia. Lett Appl Microbiol 19(1): 24–25.
24. Carson CF, Hammer KA, Riley TV. 1995. Broth microdilution method for determining the susceptibility of Escherichia coli and Staphylococcus aureus to the essential oil of Melaleuca alternifolia (tea tree oil). Microbios 82: 181–185.
25. Carson CF, Hammer KA, Riley TV. 1996. In vitro activity of the essential oil of Melaleuca alternifolia against Streptococcus spp. J Antimicrob Chemother 37: 1177–1178.
26. Carson C, Hammer K, Riley T. 2006. Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 19(1): 50–62.
27. Carson CF, Smith DW, Lampacher GJ, Riley TV. 2008. Use of deception to achieve double-blinding in a clinical trial of Melaleuca alternifolia (tea tree) oil for the treatment of recurrent herpes labialis. Contemp Clin Trials 29(1): 9–12.
28. Catalán A, Pacheco JG, Martínez A, Mondaca MA. 2008. In vitro and in vivo activity of Melaleuca alternifolia mixed with tissue conditioner on Candida albicans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105(3): 327–332.
29. Chabir N, Romdhane M, Valentin A, et al. 2011. Chemical study and antimalarial, antioxidant, and anticancer activities of Melaleuca armillaris (Sol Ex Gateau) Sm essential oil. J Med Food 14: 1383–1388.
30. Chin KB, Cordell B. 2013. The effect of tea tree oil (Melaleuca alternifolia) on wound healing using a dressing model. J Altern Complement Med 19(12): 942–945.
31. Christoph F, Kaulfers PM, Stahl-Biskup E. 2000. A comparative study of the in vitro antimicrobial activity of tea tree oils s.l. with special reference to the activity of beta-triketones. Planta Med 66: 556–560.
32. Conde LF, Rockwood DL, Fisher RF, 1981. Growth studies on Melaleuca, Proceedings of Melaleuca symposium. Sept. 23–24, 1980. Florida Division of Forestry, pp. 23–28.
33. Cox S, Mann C, Markham J, et al. 2000. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J Appl Microbiol 88(1): 170–175.
34. D'Auria FD, Laino L, Strippoli V, et al. 2001. In vitro activity of tea tree oil against Candida albicans mycelial conversion and other pathogenic fungi. J Chemother 13: 377–383.
35. Dhinahar S, Lakshmi T. 2011. Role of botanicals as antimicrobial agents in management of dental infections – a review. Int J Pharma Bio Sci 2: 690–704.
36. Di Vito M, Mattarelli P, Modesto M, et al. 2015. In vitro activity of tea tree oil vaginal suppositories against Candida spp. and probiotic vaginal microbiota. Phytother Res 29(10): 1628–1633.
37. Doran NC. 1999. Cajuput oil. In Tea Tree: The Genus Melaleuca, Southwell I, Lowe R (eds). Overseas Publishers Association: UK; 274.
38. Dryden MS, Dailly S, Crouch M. 2004. A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J Hosp Infect 56(4):283–286.
39. Edmondson M, Newall N, Carville K, Smith J, Riley TV, Carson CF. 2011. Uncontrolled, open-label, pilot study of tea tree (Melaleuca alternifolia) oil solution in the decolonisation of methicillin-resistant Staphylococcus aureus positive wounds and its influence on wound healing. Int Wound J 8: 375–384.
40. Elgendy EA, Ali SA-M, Zineldeen DH. 2013. Effect of local application of tea tree (Melaleuca alternifolia) oil gel on long pentraxin level used as an adjunctive treatment of chronic periodontitis: a randomized controlled clinical study. J Indian Soc Periodontol 17(4): 444–448.
41. Elsom GKF, Hide D. 1999. Susceptibility of methicillin-resistant Staphylococcus aureus to tea tree oil and mupirocin. J Antimicrob Chemother 43: 427–428.
42. Enshaieh S, Jooya A, Siadat AH, Iraji F. 2007. The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study. Indian J Dermatol Venereol Leprol 73(1): 22–25.
43. European Medicines Agency (EMA) - Committee on Herbal Medicinal Products (HMPC). 2013. Assessment report on Melaleuca alternifolia Maiden and Betch Cheel, M. linariifolia Smith, M. dissitiflora F.Mueller and/or other species of elaleuca, aetheroleum. EMA/HMPC/320932/2012.
44. Falci SP, Teixeira MA, Chagas PF, et al. 2015. Antimicrobial activity of Melaleuca sp. oil against clinical isolates of antibiotics resistant Staphylococcus aureus. Acta Cir Bras 30: 401–496.
45. Farag RS, Daw ZY, Mahassen MA, Safaa HM. 1998. Biochemical and biological studies on some tea trees (Melaleuca spp.) essential oil. Adv Food Sci 20: 153–162.
46. Farag RS, Shalaby AS, El-Baroty GA, Ibrahim NA, Ali MA, Hassan EM. 2004. Chemical and biological evaluation of the essential oils of different Melaleuca species. Phytother Res 18: 30–35.
47. Feinblatt HM. 1960. Cajeput-type oil for the treatment of furunculosis. J Natl Med Assoc 52(1): 32–34.
48. Fernández-Calienes Valdés A, Mendiola Martínez J, Scull Lizama R, Vermeersch M, Cos P, Maes L. 2008. In vitro anti-microbial activity of the Cuban medicinal plants Simarouba glauca DC, Melaleuca leucadendron L and Artemisia absinthium L. Mem Inst Oswaldo Cruz 103(6): 615–618.
49. Gan W. 1965. Manual of Medicinal Plants in Taiwan, National Research Institute of Chinese Medicine 3: Taipei City, Taiwan.
50. Gao Y-Y, Di Pascuale MA, Elizondo A, Tseng SC. 2007. Clinical treatment of ocular demodecosis by lid scrub with tea tree oil. Cornea 26(2): 136–143.
51. Gnatta JR, Pinto FMG, Bruna CQM, Padoveze MC, Graziano KU, Silva MJPD. 2015. Comparison of hand hygiene antimicrobial efficacy: Melaleuca alternifolia essential oil versus triclosan versus chlorhexidine. Antimicrob Resist Infect Control 4: 1212–1219.
52. Greenway M. 1994. Litter accession and accumulation in a Melaleuca quinquenervia (Cav.) ST Blake wetland in south-eastern Queensland. J Mar Freshw Res 45(8): 1509–1519.
53. Griffin SG, Markham JL, Leach DN. 2000. An agar dilution method for the determination of the minimum inhibitory concentration of essential oils. J Essent Oil Res 12: 249–255.
54. Groppo F, Ramacciato J, Simoes R, Florio F, Sartoratto A. 2002. Antimicrobial activity of garlic, tea tree oil, and chlorhexidine against oral microorganisms. Int Dent J 52(6): 433–437.
55. Gustafson JE, Liew YC, Chew S, et al. 1998. Effects of tea tree oil on Escherichia coli. Lett Appl Microbiol 26: 194–198.
56. Hammer KA, Carson CF, Riley TV. 1996. Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). Am J Infect Control 24: 186–189.
57. Hammer KA, Carson CF, Riley TV. 1999. In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil. Antimicrob Agents Chemother 43: 196.
58. Hammer KA, Carson CF, Riley TV. 2002. In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi. J Antimicrob Chemother 50: 195–199.
59. Hammer KA, Carson CF, Riley TV. 2003a. Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. J Appl Microbiol 95: 853–860.
60. Hammer KA, Dry L, Johnson M, Michalak EM, Carson CF, Riley TV. 2003b. Susceptibility of oral bacteria to Melaleuca alternifolia (tea tree) oil in vitro. Oral Microbiol Immunol 18: 389–392.
61. Hammer KA, Carson CF, Riley TV. 2004. Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. J Antimicrob Chemother 53: 1081–1085.
62. Harden GJ. 1990. Flora of New South Wales. UNSW Press: Sydney, Australia.
63. Hayouni EA, Bouix M, Abedrabba M, Leveau JY, Hamdi M. 2008. Mechanism of action of Melaleuca armillaris (Sol. Ex Gaertu) Sm. essential oil on six LAB strains as assessed by multiparametric flow cytometry and automated microtiter-based assay. Food Chem 111: 707–718.
64. Hendry ER, Worthington T, Conway BR, Lambert PA. 2009. Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures. J Antimicrob Chemother 64: 1219–1225.
65. Hiermann A, Bucar F. 1994. Influence of some traditional medicinal plants of Senegal on prostaglandin biosynthesis. J Ethnopharmacol 42(2): 111–116.
66. Holliday I. 2004. Melaleucas: A Field and Garden Guide. Reed New Holland Publishers.
67. Hussein SA, Hashim ANM, El-Sharawy R, et al. 2007. Ericifolin (I): an eugenol 5-O-galloylglucoside and other phenolics from Melaleuca ericifolia. Phytochemistry 68: 1464–1470.
68. ISO. 2004. Oil of Melaleuca, terpinen-4-ol type (tea tree oil).
69. Jandourek A, Vaishampayan JK, Vazquez JA. 1998. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. AIDS 12(9): 1033–1037.
70. Johns MR, Johns JE, Rudolph V. 1992. Steam distillation of tea tree (Melaleuca alternifolia) oil. J Sci Food Agr 58(1): 49–53.
71. Joksimovic N, Spasovski G, Joksimovic V, Andreevski V, Zuccari C, Omini C. 2012. Efficacy and tolerability of hyaluronic acid, tea tree oil and methyl-sulfonyl-methane in a new gel medical device for treatment of haemorrhoids in a double-blind, placebo-controlled clinical trial. Updates Surg 64(3): 195–201.
72. Joshi RK. 2013. Chemical composition, in vitro antimicrobial and antioxidant activities of the essential oils of Ocimum gratissimum, O. sanctum and their major constituents. Indian J Pharm Sci 75: 457–462.
73. Julie ML. 2006. Biological Activity of Tea Tree Oil In: Tea Tree the Genus Melaleuca (Medicinal and Aromatic Plant: Industerial Profiles). Harwood Academic Publisher: Abingdon, United Kingdom.
74. Khumsupan P, Gritsanapan W. 2014. Anti-acne activity of Garcinia mangostana L.: a review. Plant Sci Today 1(3): 147–150.
75. Kim JH, Liu KH, Yoon Y, Sornnuwat Y, Kitirattrakarn T, Anantachoke C. 2005. Essential leaf oils from Melaleuca cajuputi. Tradit Med Nutraceuticals 6: 65–72.
76. Ko K, Juntarajumnong W, Chandrapatya A. 2009. Repellency, fumigant and contact toxicities of Melaleuca cajuputi Powell against Sitophilus zeamais Motschulsky and Tribolium castaneum Herbst. Thai J Agric Sci 42: 27–33.
77. Kwon HH, Yoon JY, Park SY, Min S, Suh DH. 2014. Comparison of clinical and histological effects between Lactobacillus-fermented Chamaecyparis obtusa and tea tree oil for the treatment of acne: an eight-week double-blind randomized controlled split-face study. Dermatol 229(2): 102–109.
78. Lassak EV, Brophy JJ. 2014. The leaf essential oils of Melaleuca deanii F. Muell. and Melaleuca hypericifolia Sm. (Myrtaceae). J Essent Oil Bear PI 17. https://doi.org/10.1080/0972060X.0972014.0923343.
79. Lee CK. 1998. Ursane triterpenoids from leaves of Melaleuca leucadendron. Phytochemistry 49: 1119–1122.
80. Lee CK. 1999. Leucadenone A-D, the novel class flavanone from the leaves of Melaleuca leucadendron L. Tetrahedron Lett 40: 7255–7259.
81. Li L, Li ZW, Yin ZQ, et al. 2014. Antibacterial activity of leaf essential oil and its constituents from Cinnamomum longepaniculatum. Int J Clin Exp Med 7: 1721–1727.
82. Lis-Balchin M, Hart S, Deans S. 2000. Pharmacological and antimicrobial studies on different tea-tree oils (Melaleuca alternifolia, Leptospermum scoparium or Manuka and Kunzea ericoides or Kanuka), originating in Australia and New Zealand. Phytother Res 14(8): 623–629.
83. Lohakachornpan P, Rangsipanuratn W. 2001. Chemical compositions and antimicrobial activities of essential oil from Melaleuca leucadendron var. minor. Thai J Pharm Sci 25: 133–139.
84. Mahady G. 2005. Medicinal plants for the prevention and treatment of bacterial infections. Curr Pharm Des 11(19): 2405–2427.
85. Mann CM, Markham JL. 1998. A new method for determining the minimum inhibitory concentration of essential oils. J Appl Microbiol 84: 538–544.
86. Mantle D, Gok MA, Lennard T. 2001. Adverse and beneficial effects of plant extracts on skin and skin disorders. Adverse Drug React Toxicol Rev 20(2): 89–103.
87. Markham JL. 1999. Biological activity of tea tree oil. In Tea Tree: The Genus Melaleuca, Southwell I, Lowe R (eds). Overseas Publishers Association: UK; 274.
88. Markum E, Baillie J. 2012. Combination of essential oil of Melaleuca alternifolia and iodine in the treatment of Molluscum contagiosum in children. J Drugs Dermatol 11(3): 349–354.
89. Martin KW, Ernst E. 2004. Herbal medicines for treatment of fungal infections: a systematic review of controlled clinical trials. Mycoses 47(3–4): 87–92.
90. Mickiene R, Bakutis B, Baliukoniene V. 2011. Antimicrobial activity of two essential oils. Ann Agric Environ Med 18: 139–144.
91. Millar BC, Moore JE. 2008. Successful topical treatment of hand warts in a paediatric patient with tea tree oil (Melaleuca alternifolia). Complement Ther Clin Pract 14(4): 225–227.
92. Mondello F, De Bernardis F, Girolamo A, Salvatore G, Cassone A. 2003. In vitro and in vivo activity of tea tree oil against azole -susceptible and -resistant human pathogenic yeasts. J Antimicrob Chemother 51: 1223–1229.
93. Monzon R. 1995. Traditional medicine in the treatment of parasitic diseases in the Philippines. Southeast Asian J Trop Med Public Health 26(3): 421–428.
94. Nazzaro F, Fratianni F, Martino LD, Coppola R, Feo VD. 2013. Effect of essential oils on pathogenic bacteria. Pharmaceuticals 6: 1451–1474.
95. Nelson RRS. 1997. In-vitro activities of five plant essential oils against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 40: 305–306.
96. Nenoff P, Haustein UF, Brandt W. 1996. Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Skin Pharmacol 9: 388–394.
97. Nguyen MTT, Awale S, Tezuka Y, Le Tran Q, Watanabe H, Kadota S. 2004. Xanthine oxidase inhibitory activity of Vietnamese medicinal plants. Biol Pharm Bull 27(9): 1414–1421.
98. Niang S, Tine Y, Diatta B, et al. 2015. Negative cutaneous effects of medicinal plants in Senegal. Br J Dermatol 173(S2): 26–29.
99. Nielsen JB 2005. Literature review on tea tree oil: Toxicity profiles for tea tree oil, constituents of tea tree oil and known oxidation products: A report prepared for the Australian Rural Industries Research Development Corporation (RIRDC). Report No.: PRJ-002403.
100. Oliva B, Piccirilli E, Ceddia T, Pontieri E, Aureli P, Ferrini A. 2003. Antimycotic activity of Melaleuca alternifolia essential oil and its major components. Lett Appl Microbiol 37: 185–187.
101. Packer J, Brouwer N, Harrington D, et al. 2012. An ethnobotanical study of medicinal plants used by the Yaegl Aboriginal community in northern New South Wales, Australia. J Ethnopharmacol 139(1): 244–255.
102. Padalia RC, Verma RS, Chauhan A, Chanotiya CS. 2015a. The essential oil composition of Melaleuca leucadendra L. grown in India: A novel source of (E)-nerolidol. Ind Crops Prod 69: 224–227.
103. Padalia RC, Verma RS, Chauhan A, Goswami P, Verma SK, Darokar MP. 2015b. Chemical composition of Melaleuca linarrifolia Sm. from India: a potential source of 1,8-cineole. Ind Crops Prod 63: 264–268.
104. Papadopoulos CJ, Carson CF, Hammer KA, Riley TV. 2006. Susceptibility of pseudomonads to Melaleuca alternifolia (tea tree) oil and components. J Antimicrob Chemother 58: 449–451.
105. PeÑa EF. 1962. Melaleuca Alternifolia oil its use for Trichomonal vaginitis and other vaginal infections. Obstet Gynecol 19(6): 793–795.
106. Raman A, Weir U, Bloomfield SF. 1995. Antimicrobial effects of tea-tree oil and its major components on Staphylococcus aureus, Staph. epidermidis and Propionibacterium acnes. Lett Appl Microbiol 21: 242–245.
107. Rattanaburi S, Mahabusarakam W, Phongpaichit S, Carroll AR. 2013. A new chromone from the leaves of Melaleuca cajuputi Powell. Nat Prod Res 27: 221–225.
108. Reichling J, Harkenthal M, Saller R. 2006. Australisches Teebaumöl (Melaleucae aetheroleum). Pharmazeutische Qualität, Wirksamkeit und Toxizität. Schweiz Z Ganzheitsmed 18(4): 193–200.
109. Reichling J, Schnitzler P, Suschke U, Saller R. 2009. Essential oils of aromatic plants with antibacterial, antifungal, antiviral, and cytotoxic properties – an overview. Forsch Komplementmed 16: 79–90.
110. Rosato A, Vitali C, Gallo D, Balenzano L, Mallamaci R. 2008. The inhibition of Candida species by selected essential oils and their synergism with amphotericin B. Phytomedicine 15: 635–638.
111. Rubel DM, Freeman S, Southwell IA. 1998. Tea tree oil allergy: what is the offending agent? Report of three cases of tea tree oil allergy and review of the literature. Australas J Dermatol 39(4): 244–247.
112. Saifudin A, Usia T, AbLallo S, Morita H, Tanaka K, Tezuka Y. 2016. Potent water extracts of Indonesian medicinal plants against PTP1B. Asian Pac J Trop Biomed 6(1): 38–43.
113. Santamaria M, Petermann KD, Vedovello SAS, Degan V, Lucato A, Franzini CM. 2014. Antimicrobial effect of Melaleuca alternifolia dental gel in orthodontic patients. Am J Orthod Dentofacial Orthop 145(2): 198–202.
114. Sarr FB, Sarr M, Diop D, et al. 2010. In vitro modulation of tracheal smooth muscle reactivity by extracts of some Senegalese medicinal plants. J Med Plants Res 4(1): 013–018.
115. Sasaki S, Yagi H, Yamanoshita T, et al. 1995. Reforestation trial of degraded peat swamp forests and sand dune in Narathiwat, Thailand. In A Tropical Swamp Forest Ecosystem and Its Greenhouse Gas Emission, Vijarnsorn P, Suzuki K, Kyuma K, Wada E, Nagano T, Takai Y (eds); 55–61.
116. Satchell AC, Saurajen A, Bell C, Barnetson RS. 2002. Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study. Australas J Dermatol 43(3): 175–178.
117. Sfeir J, Lefrançois C, Baudoux D, Derbré S, Licznar P. 2013. In vitro antibacterial activity of essential oils against Streptococcus pyogenes. Evid Based Complement Alternat Med 269161 9.
118. Shapiro S, Meier A, Guggenheim B. 1994. The antimicrobial activity of essential oils and essential oil components towards oral bacteria. Oral Microbiol Immunol 9: 202–208.
119. Sharopov F. 2015. Phytochemistry and Bioactivities of Selected Plant Species with Volatile Secondary Metabolites. Ruperto-Carola University of Heidelberg: Heidelberg; 130.
120. Shemesh A, Mayo W. 1991. Australian tea tree oil: a natural antiseptic and fungicidal agent. Aust J Pharm 72: 802–803.
121. Sherry E, Boeck H, Warnke PH. 2001. Topical application of a new formulation of eucalyptus oil phytochemical clears methicillin-resistant Staphylococcus aureus infection. Am J Infect Control 29: 346.
122. Silva CJ, Barbosa LC, Maltha CR, Pinheiro AL, Ismail FM. 2007. Comparative study of the essential oils of seven Melaleuca (Myrtaceae) species grown in Brazil. Flavour Frag 22: 474–478.
123. Silva CJ, Barbosa LCA, Demuner AJ, et al. 2010. Chemical composition and antibacterial activities from the essential oils of Myrtaceae species planted in Brazil. Quim Nova 33: 104–108.
124. Sinha DJS, Vasudeva A, Jaiswal N, Garg P, Tyagi SP, Singh J. 2015. Antibacterial efficacy of Melaleuca alternifolia (Tea tree oil), Curcuma longa (Turmeric), 2% chlorhexidine, and 5% sodium hypochlorite against Enterococcus faecalis: an in vitro study. Saudi Endod 5: 182–186.
125. Skopinska-Rózewska E, Furmanowa M, Guzewska J, Sokolnicka I, Sommer E, Bany J. 2002. The effect of Centella asiatica, Echinacea purpurea and Melaleuca alternifolia on cellular immunity in mice. Cent Eur J Immunol 27(4): 142–148.
126. Smith HG. 1922. Occurrence of l-phellandrene in the oil of Meleluca acuminata. J Proc R Soc N S W 56: 159–161.
127. Smith HG, Carter PG, Read J. 1924. Phellandrenes. J Chem Soc Trans 125: 930–940.
128. Soukoulis S, Hirsch R. 2004. The effects of a tea tree oil-containing gel on plaque and chronic gingivitis. Aust Dent J 49(2): 78–83.
129. Southwell I, Lowe R. 2003. Tea Tree: The Genus Melaleuca. CRC Press: Boca Raton, Florida, United States.
130. Southwell I, Russell M, Smith RL, Brophy JJ, Day J. 2005. Melaleuca teretifolia, a novel aromatic and medicinal plant from Australia. Acta Hort 677: 79–83.
131. Syed T, Qureshi Z, Ali S, Ahmad S, Ahmad S. 1999. Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop Med Int Health 4(4): 284–287.
132. Takarada K. 2005. The effects of essential oils on periodontopathic bacteria and oral halitosis. Oral Dis 11: 115.
133. Tang JW, Cao M, Zhang JH, Li MH. 2010. Litterfall production, decomposition and nutrient use efficiency varies with tropical forest types in Xishuangbanna, SW China: a 10-year study. Plant and Soil 335(1–2): 271–288.
134. Tipping PW, Martin MR, Pratt PD, Wheeler GS, Gettys LA. 2016. Response of two chemotypes of Melaleuca quinquenervia (Myrtales: Myrtaceae) saplings to colonization by specialist herbivores. Fla Entomol 99: 77–81.
135. Tong MM, Altman PM, Barnetson RS. 1992. Tea tree oil in the treatment of tinea pedis. Australas J Dermatol 33(3): 145–149.
136. Trombetta D, Castelli F, Sarpietro MG, et al. 2005. Mechanisms of antibacterial action of three monoterpenes. Antimicrob Agents Chemother 49: 2474–2478.
137. Usia T, Iwata H, Hiratsuka A, Watabe T, Kadota S, Tezuka Y. 2006. CYP3A4 and CYP2D6 inhibitory activities of Indonesian medicinal plants. Phytomedicine 13(1): 67–73.
138. Valdes AF, Martínez JM, Lizama RSl, Vermeersch M, Cos P, Maes L. 2008. In vitro antimicrobial activity of the Cuban medicinal plants Simarouba glauca DC, Melaleuca leucadendron L and Artemisia absinthium L. Mem Inst Oswaldo Cruz 103: 615–618.
139. Vazquez JA, Arganoza MT, Boikov D, Vaishampayan JK, Akins RA. 2000. In vitro susceptibilities of Candida and Aspergillus species to Melaleuca alternifolia (tea tree) oil. Rev Iberoam Micol 17: 60–63.
140. Victoria DA. 2005. Those amazing tea tree oils. Karen MacKenzie Australia ISBN: 1-900-80603-7. http://www.health247.info/healthbites/bookpdfs/teatreebook.pdf.
141. Vlachojannis C, Chrubasik-Hausmann S, Hellwig E, Al-Ahmad A. 2015. A preliminary investigation on the antimicrobial activity of Listerine®, its components, and of mixtures thereof. Phytother Res 29: 1590–1594.
142. Vlachojannis C, Al-Ahmad A, Hellwig E, Chrubasik S. 2016. Listerine® products: an update on the efficacy and safety. Phytother Res 30: 367–373.
143. Wigmore S, Naiker M, Bean D. 2016. Antimicrobial activity of extracts from native plants of temperate Australia. Pharmacogn Commun 6: 80–84.
144. Woodall S, 1981. Site requirements for Melaleuca seedling establishment, Proceedings of Melaleuca symposium. Sept. 23–24, 1980. Florida Division of Forestry, pp. 9–15.
145. Wright MH, Greene AC, Cock IE. 2015. Inhibition of Bacillus anthracis growth by Australian native plants used traditionally as antibacterial medicines. Pharmacog J 7: 389–396.